Ohio Bioscience News

Click a news item to be directed to the full story. Send your news to bioohio@bioohio.com.

Found 5901 Results

P2D Bioscience to collaborate with Bangalore-based Advinus Therapeutics

Cincinnati’s P2D Bioscience, a CNS-focused specialty pharmaceutical company, and Advinus Therapeutics, an India-based drug discovery and development company, have initiated a research and development collaboration to advance therapies for Attention Deficit Hyperactivity Disorder (ADHD). ADHD is the most commonly diagnosed psychiatric disorder in children, with symptoms continuing into adulthood in up to 50% of cases. Recent estimates […]

July 26, 2012

BioOhio event to highlight “big data” in bioscience R&D

Biomedical research is producing increasingly larger and more complex datasets, including genome sequences, proteomic profiles, in silico drug screening, and high-res images. Experts believe that new technologies to handle so-called “big data” will stimulate the next transformative step toward realizing the potential of biological research across sectors. Earlier this year, the White House announced a […]

July 25, 2012

Ohio State and Cleveland Clinic tie the commercialization knot

It seems two Ohio bioscience heavyweights have been talking lately, and the results of those talks are pretty monumental. At a press conference this morning in Columbus, the two titans announced an alliance between Ohio State’s Technology Commercialization and Knowledge Transfer Office and Cleveland Clinic Innovations. Details of the commercialization partnership can be found on a […]

July 24, 2012

Battelle wins $102M biodefense research contract

Battelle has won a single-source award from the NIH for evaluation and testing services for vaccines and other biologics for infectious diseases. The work, worth as much as $102.5 million for 10 years, will be conducted at Battelle’s biosafety level 3 laboratories and new toxicology research facility in West Jefferson, Ohio. The award will support […]

July 20, 2012

NAMSA’s latest acquisition expands imaging and clinical services

Medical device-focused CRO NAMSA has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis. “NAMSA is very pleased to now be able to offer The Integra Group’s imaging lab, biostatistics and physician training services along with our world-class expertise in R&D, biocompatibility and clinical research,” said NAMSA President & CEO John […]

July 20, 2012

Neuros Medical secures 2nd funding round

Neuros Medical, a medical device company in Cleveland, has raised a $3.5 million round of funding, led by Boston Scientific and Glengary LLC. Also joining in the round were current investors Case Tech Ventures, JumpStart Ventures, NorthCoast Angel Fund, Ohio Tech Angel Fund, Queen City Angel Fund III, Physician Investment Group, as well as new […]

July 18, 2012

STERIS to acquire US Endoscopy

STERIS Corporation announced today the signing of a definitive agreement to acquire all the outstanding shares of privately-owned US Endoscopy. Founded in 1991 and based in Mentor, Ohio, US Endoscopy is a leader in the design, manufacture and sale of therapeutic and diagnostic medical devices and support accessories used in the gastrointestinal (GI) endoscopy markets […]

July 17, 2012

BioOhio in D.C. to update Ohio’s Congressional delegation

Today BioOhio is in Washington D.C. to host a one-hour Ohio Bioscience Industry Update for Ohio’s Congressional delegation in the Capitol Visitors Center at the invitation of Senator Sherrod Brown, Senator Rob Portman, and Representative Steve Stivers. BioOhio President & CEO Tony Dennis will report on industry growth in Ohio over the past decade and […]

July 12, 2012